Laure S.
- Country
- France
- Department
- Pediatrics
Research Overview
- Phase 2 Multicentre Randomized Trial of Mifamurtide with Post-Operative Chemotherapy in High-Risk Osteosarcoma Patients
- Randomized Study of Zoledronic Acid Monohydrate in Combination Chemotherapy for High-Grade Osteosarcoma in Pediatric and Adult Patients
- Evaluation of Regorafenib Addition to VDC/IE Chemotherapy and Maintenance Vinorelbine-Cyclophosphamide in Newly Diagnosed Metastatic Ewing Sarcoma
Data & Insights
Has run more than one trial at 41 of 71 partner sites.
Specializations
Orthopedic Oncology
The investigator specializes in the treatment of high-grade osteosarcoma, with particular focus on comprehensive therapeutic approaches combining surgery and chemotherapy protocols.
- Primary bone malignancies
- Metastatic bone cancer management
- Surgical intervention strategies
Their expertise extends to treating osteosarcoma across different age groups, from pediatric to adult patients.
Therapeutic Innovation
The investigator explores advanced treatment modalities including combination therapy approaches and novel therapeutic agents such as zoledronic acid and mifamurtide.
- Adjuvant therapy protocols
- Post-operative treatment strategies
- High-risk patient management
Their work encompasses both localized and metastatic disease scenarios, with emphasis on improving survival outcomes.
Clinical Assessment
The investigator focuses on evaluating treatment response parameters and developing strategies for patients with varying risk profiles.
- Progression-free survival assessment
- Histological response evaluation
- Risk stratification approaches
Their expertise includes monitoring treatment efficacy through various clinical endpoints and response markers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.